162 related articles for article (PubMed ID: 2568835)
1. Characterization of the class I HLA 9.2-kb PVU II restriction fragment length polymorphism. Linkage to HLA-A and lack of disease association.
Ahearn JM; Calomiris JJ; Wigley FM; Jabs DA; Bias WB; Hochberg MC
Arthritis Rheum; 1989 Jul; 32(7):870-6. PubMed ID: 2568835
[TBL] [Abstract][Full Text] [Related]
2. Association between ankylosing spondylitis and a 9.2 kb Pvu II class I HLA DNA restriction fragment: a reassessment.
Durand JP; Taurog JD
J Rheumatol; 1988 Jul; 15(7):1119-22. PubMed ID: 2902225
[TBL] [Abstract][Full Text] [Related]
3. [TaqI restriction polymorphism and the HLA-B27 allele in ankylosing spondylitis].
Huetz F; Lucotte G; Kahan A; Amor B
Rev Rhum Mal Osteoartic; 1987 Mar; 54(3):175-8. PubMed ID: 2884722
[TBL] [Abstract][Full Text] [Related]
4. HLA-B27 subtypes and HLA class II alleles in Japanese patients with anterior uveitis.
Konno Y; Numaga J; Tsuchiya N; Ogawa A; Islam SM; Mochizuki M; Mitsui H; Oda H; Maeda H
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1838-44. PubMed ID: 10393058
[TBL] [Abstract][Full Text] [Related]
5. TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients.
González S; Torre-Alonso JC; Martínez-Borra J; Fernández Sánchez JA; López-Vazquez A; Rodríguez Pérez A; López-Larrea C
J Rheumatol; 2001 Jun; 28(6):1288-93. PubMed ID: 11409121
[TBL] [Abstract][Full Text] [Related]
6. HLA-A*2402 and a microsatellite (D6S248) are secondary independent susceptibility markers to ankylosing spondylitis in Basque patients.
de Juan MD; Reta A; Belzunegui J; Figueroa M; Maruri N; Cuadrado E
Hum Immunol; 2004 Feb; 65(2):175-80. PubMed ID: 14969772
[TBL] [Abstract][Full Text] [Related]
7. Association between a 10 kb Pvu II restriction fragment of genomic DNA with the hemochromatosis gene.
Lucotte G; Coulondre C
Exp Clin Immunogenet; 1986; 3(4):219-23. PubMed ID: 2908538
[TBL] [Abstract][Full Text] [Related]
8. LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis.
Maksymowych WP; Tao S; Vaile J; Suarez-Almazor M; Ramos-Remus C; Russell AS
J Rheumatol; 2000 Jan; 27(1):183-9. PubMed ID: 10648037
[TBL] [Abstract][Full Text] [Related]
9. The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27.
McGarry F; Walker R; Sturrock R; Field M
J Rheumatol; 1999 May; 26(5):1110-6. PubMed ID: 10332976
[TBL] [Abstract][Full Text] [Related]
10. MICA gene polymorphisms and HLA-B27 subtypes in Japanese patients with HLA-B27-associated acute anterior uveitis.
Goto K; Ota M; Ando H; Mizuki N; Nakamura S; Inoue K; Yabuki K; Kotake S; Katsuyama Y; Kimura M; Inoko H; Ohno S
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):634-7. PubMed ID: 9501876
[TBL] [Abstract][Full Text] [Related]
11. [Disequilibrium linkage between the polymorphism in exons 2, 3 and 4 of the MICA gene and HLA-B antigen of patient with ankylosing spondylitis].
Su H; Wang BL; Zhang XJ; Hao JH; Xiao Q; Ye DQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):446-8. PubMed ID: 16883538
[TBL] [Abstract][Full Text] [Related]
12. HLA-A*9, a probable secondary susceptibility marker to ankylosing spondylitis in Basque patients.
de Juan MD; Reta A; Cancio J; Belzunegui J; Cuadrado E
Tissue Antigens; 1999 Feb; 53(2):161-6. PubMed ID: 10090616
[TBL] [Abstract][Full Text] [Related]
13. Association of a 9.2-kilobase Pvu II class I major histocompatibility complex restriction fragment length polymorphism with ankylosing spondylitis.
McDaniel DO; Acton RT; Barger BO; Koopman WJ; Reveille JD
Arthritis Rheum; 1987 Aug; 30(8):894-900. PubMed ID: 2888467
[TBL] [Abstract][Full Text] [Related]
14. Taq I polymorphism of HLA class I genes in an ankylosing spondylitis family.
Lucotte G; Huetz F; Mariotti M; Cavelier B; Deshayes P; Amor B
Exp Clin Immunogenet; 1987; 4(4):207-10. PubMed ID: 2908513
[TBL] [Abstract][Full Text] [Related]
15. Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA-B27 extended haplotypes in Sardinia.
Cascino I; Paladini F; Belfiore F; Cauli A; Angelini C; Fiorillo MT; Mathieu A; Sorrentino R
Arthritis Rheum; 2007 Aug; 56(8):2640-51. PubMed ID: 17665395
[TBL] [Abstract][Full Text] [Related]
16. Complementation with HLA-A and HLA-D locus alleles in ankylosing spondylitis with peripheral arthritis.
Aaron S; Miller ML; Howard J; Fraser PA; Jackson JM; Larson MG; Glass DN
J Rheumatol; 1985 Jun; 12(3):553-7. PubMed ID: 3876437
[TBL] [Abstract][Full Text] [Related]
17. Association of RFLP of HLA class I genes with Chinese ankylosing spondylitis patients.
Lin XY; Wang Y; Sun J; Wang FQ; Ni LQ; Chang LY; Chen SS
Tissue Antigens; 1989 Nov; 34(5):279-83. PubMed ID: 2576476
[TBL] [Abstract][Full Text] [Related]
18. Non-association between 9.2 KB PvuII RFLP and seronegative spondyloarthropathies in Spain.
Cañete JD; Sanmartí R; Collado A; Ercilla G; Armengol P; Vendrell J; Gratacós J; Muñoz-Gomez J
Br J Rheumatol; 1992 Nov; 31(11):743-6. PubMed ID: 1360307
[TBL] [Abstract][Full Text] [Related]
19. HLA in ankylosing spondylitis: is HLA-B27 the only MHC gene involved in disease pathogenesis?
Reveille JD; Suarez Almazor ME; Russell AS; Go RC; Appleyard J; Barger BO; Acton RT; Koopman WJ; McDaniel DO
Semin Arthritis Rheum; 1994 Apr; 23(5):295-309. PubMed ID: 7913556
[TBL] [Abstract][Full Text] [Related]
20. Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis.
Nicknam MH; Mahmoudi M; Amirzargar AA; Ganjalikhani Hakemi M; Khosravi F; Jamshidi AR; Amirkhani A; Ansaripour B; Pourpak Z; Moin M; Nikbin B
Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):19-24. PubMed ID: 18322308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
